RVAC Medicines
MRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$560—840m (Dealroom.co estimates Apr 2022.)
Singapore (HQ)
Authorizing premium user...